Okay, it’s time to stop pretending that the “retail price” of a graphics card means anything at all. AMD made a big press splash about launching its new Radeon RX 9070 cards at $550 and $600 ...

It spoke to a graphic through-line which ran through the season’s collections, seeing streamlined, engineered silhouettes – oftentimes in black – speak to a renewed focus on design and construction.

Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.

This is an awful, awful lot of monitor for your money. As the "Graphic Pro" branding implies, this monitor gives you a lot of the features and performance of much more expensive content-creation ...

Shares of NASDAQ VERX opened at $35.71 on Thursday. The firm’s 50 day moving average price is $46.33 and its 200-day moving average price is $46.38. The company has a market cap of $5.65 billion ...

Journavx works differently than other available medications, and its developer, the biotechnology juggernaut Vertex Pharmaceuticals, has positioned it as an important, non-opioid option for pain ...

AMD is preparing to launch its RX 9000 series graphics cards. Nvidia has been prioritizing AI accelerators, so supplies of its latest graphics cards are tight. AMD has a chance to win considerable ...

Jim Lebenthal names Vertex Pharmaceuticals as his final trade. Joshua Brown says Netflix is close to its 52-week high. Feel unsure about the market’s next move? Copy trade alerts from Matt Maley ...

The assessment showed that Trinasolar Vertex S+ 500W+ modules can reduce the structure cost by up to 12.01%. The structure cost for the four PV modules was $29,936, $30,663, $33,936 and $30,542 ...

Vertex has established itself as a frontrunner in the indirect tax automation space, serving over 4,800 customers, including more than 60% of the Fortune 500. The company’s solutions are ...